COVID-19 can alter blood work across a surprisingly wide range of tests, from basic cell counts to inflammatory markers, organ function panels, and even micronutrient levels. Some of these changes are subtle and resolve within weeks, while others persist for months and serve as warning flags for disease severity. Understanding what shifts to expect on a lab report after a SARS-CoV-2 infection helps put abnormal results in context, whether you are dealing with an active case or lingering post-COVID symptoms.
White Blood Cell Shifts and the Complete Blood Count
The most commonly reported change on a standard complete blood count (CBC) during COVID-19 is lymphopenia, meaning your lymphocyte count drops. Lymphocytes are the immune cells responsible for targeted viral defense, and SARS-CoV-2 appears to deplete them in ways that track with how sick you get. Alongside that drop, neutrophils, the immune cells that respond first to any threat, tend to climb. The ratio of neutrophils to lymphocytes (NLR) has become one of the cheapest and most reliable bedside indicators of COVID-19 severity.1PubMed Central. The neutrophil‐to‐lymphocyte ratio as a marker of immunosenescence and COVID‐19 outcomes in the elderly: A narrative review Patients with severe disease consistently present with more pronounced lymphopenia, higher neutrophil counts, and an NLR that independently predicts ICU admission and mortality.2PubMed Central. Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19
Platelet counts also shift, though the direction depends on the stage and severity of illness. Many hospitalized patients develop thrombocytopenia, where platelets drop below normal levels, and the degree of that drop has been linked to worse outcomes and higher mortality risk.3PubMed. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count Immune thrombocytopenia, in which the body’s immune system mistakenly attacks its own platelets, has emerged as a recognized complication of COVID-19.4PubMed Central. COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis Even when platelet numbers look normal or only mildly reduced, research has found that COVID-19 platelets behave differently: they are more “sticky,” aggregate more easily, and display surface proteins associated with clotting, giving them a prothrombotic profile that helps explain the elevated clotting risk.5PubMed Central. Platelets contribute to disease severity in COVID-19
Clotting and Coagulation Markers
One of the more alarming features of COVID-19, particularly in moderate-to-severe cases, is its effect on the coagulation system. D-dimer, a protein fragment produced when blood clots break down, rises sharply in many patients. Elevated D-dimer levels during COVID-19 have been correlated with higher rates of deep vein thrombosis, pulmonary embolism, and disseminated intravascular coagulation, and those clotting complications track closely with poor outcomes and mortality.6The Egyptian Journal of Bronchology. d-dimer as a biomarker for COVID-19-associated pulmonary thromboembolism: a narrative review from molecular pathways to the imaging findings Another coagulation marker, fibrinogen degradation products (FDP), has also shown value as a predictor of severe disease.7PubMed Central. Identification of parameters in routine blood and coagulation tests related to the severity of COVID-19
What makes COVID-19 unusual compared to many other viral infections is the sheer breadth of its clotting effects. The virus does not just trigger the standard inflammatory cascade that nudges clotting factors upward; it appears to directly affect endothelial cells lining blood vessels, creating a pro-clotting environment throughout the body. That is why clinicians started monitoring D-dimer as a routine part of COVID-19 care fairly early in the pandemic, and why many hospitalized patients received prophylactic blood thinners.
Inflammatory Markers That Spike
If there is a single biochemical theme of COVID-19, it is inflammation. Three inflammatory markers have proven especially useful in gauging severity: C-reactive protein (CRP), ferritin, and interleukin-6 (IL-6).
CRP, a general-purpose inflammation marker produced by the liver, rises substantially in most symptomatic COVID-19 patients. A meta-analysis pooling over 5,300 patients from 25 studies found that elevated CRP was associated with roughly an 84% higher risk of a poor outcome.8PubMed Central. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis Ferritin, an iron-storage protein that also rises during inflammation, showed similarly strong prognostic value in the same analysis. Critically ill patients in one study had mean ferritin levels several times higher than those with milder disease.9PubMed Central. Role of Serum Ferritin, D-Dimer, and C-Reactive Protein Parameters in COVID 19 Severity
IL-6, a cytokine that acts as a key orchestrator of the so-called “cytokine storm,” is perhaps the most studied inflammatory mediator in severe COVID-19. Patients with critical illness have significantly higher serum IL-6 (and IL-10) levels compared to those with moderate or even severe-but-stable disease.10PubMed Central. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors IL-6 exerts both pro-inflammatory and anti-inflammatory effects, and it became a direct therapeutic target: the drug tocilizumab, which blocks IL-6 signaling, was used in severe cases specifically to try to tamp down the storm.11PubMed Central. Cytokine Storm in COVID-19: Exploring IL-6 Signaling and Cytokine-Microbiome Interactions as Emerging Therapeutic Approaches Patients who died also showed significant differences in D-dimer, CRP, ferritin, and IL-18 compared to 30-day survivors, reinforcing that these inflammatory markers together paint a fairly reliable picture of disease trajectory.12PubMed Central. The intercorrelations between blood levels of ferritin, sCD163, and IL-18 in COVID-19 patients and their association to prognosis
Liver, Kidney, and Heart Markers
COVID-19 is not just a lung disease, and organ function panels often reflect that. Liver injury, measured through elevated enzymes like ALT and AST, has been observed in a significant proportion of hospitalized patients, especially in severe or critical illness. Males, older adults, and those with higher body mass index appear more susceptible to COVID-related liver dysfunction, which worsens prognosis and prolongs hospital stays.13PubMed Central. Liver injury in the era of COVID-19 The liver damage can occur even in people with no prior liver disease, though those with pre-existing chronic liver conditions face a compounding risk.
Kidney function also takes a hit. Acute kidney injury is a well-documented complication, and lab work commonly shows increased serum creatinine, elevated blood urea nitrogen, and the appearance of protein or blood in the urine.14Revista da Associação Médica Brasileira. Renal changes and acute kidney injury in covid-19: a systematic review Even in young adults with moderate disease, one study found a trend toward declining kidney filtration rates after infection, suggesting that kidney effects are not limited to the sickest patients.15PubMed Central. Investigating kidney function changes in young adults with COVID-19: Serum creatinine level, glomerular filtration rate, and biochemical profile analysis The ratio of blood urea nitrogen to creatinine (BUN/Cr) has even been identified as an independent predictor of disease severity and survival.16PubMed Central. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients
Cardiac troponin, the gold-standard blood marker for heart muscle damage, is elevated in a notable share of COVID-19 patients and is associated with arrhythmias and death.17PubMed Central. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week What is striking is how long the elevation can last. A study tracking troponin I levels found that men older than 54 with even mild COVID-19 had persistently elevated troponin from baseline through at least 9 weeks after diagnosis, and in a subcohort followed longer, the elevation remained at 14 months.18PubMed Central. Mild COVID-19 induces early, quantifiable, persistent troponin I elevations in elder men Among survivors with acute cardiac injury during hospitalization, fewer than half had recovered normal troponin levels at a follow-up roughly two and a half months later.19eBioMedicine. Persistence and predictors of acute cardiac injury in coronavirus disease 2019 (COVID-19) survivors
Blood Sugar and Thyroid Function
Even if you are not diabetic, COVID-19 can push your blood glucose upward. Stress hyperglycemia, driven by the body’s own cortisol surge during acute illness, is one mechanism. When corticosteroids like dexamethasone are used as treatment, the effect is compounded because these drugs oppose insulin action and stimulate the liver to produce more glucose.20PubMed Central. Study of HbA1c levels in non-diabetic individuals recovered from Covid-19 This matters for interpreting HbA1c, the test that reflects average blood sugar over the past two to three months. If HbA1c is checked too soon after recovery (within roughly three months), it may come back falsely elevated due to infection- and treatment-related glucose spikes, not because you have developed diabetes. Clinicians who are aware of this generally wait before drawing conclusions from a post-COVID HbA1c result.
Thyroid function tests show their own pattern of disruption. During hospitalization, low TSH levels were found in about 39% of patients in one study, and half of those patients also had low free T3. In survivors, TSH and free T3 levels generally bounced back by the time of discharge, but in patients who died they stayed permanently low, with free T3 being a predictor of mortality.21European Journal of Endocrinology. The spectrum of thyroid function tests during hospitalization for SARS COV-2 infection More broadly, thyroid dysfunction on admission was present in over half of hospitalized patients in another study, most commonly as what is called non-thyroidal illness syndrome, where thyroid hormone levels drop without the thyroid gland itself being diseased.22PubMed. The Spectrum of Thyroid Function Tests and Autoantibodies During Hospitalization and After Six Months of Discharge in COVID-19 Patients: Does COVID-19 Trigger Autoimmunity? In people with Graves’ disease, COVID-19 infection produced measurable changes in the ratio of thyroid hormones that persisted for at least three months.23PubMed Central. The impact of COVID-19 on thyroid function and psychological state of Graves’ disease: a one-year prospective study
Vitamin D and Zinc Depletion
Micronutrient panels drawn during active COVID-19 frequently show depleted levels of vitamin D and zinc. In one study of hospitalized patients, 73% were deficient in vitamin D and 52% were deficient in zinc, both significantly worse than in healthy controls.24PubMed Central. Serum vitamin D, calcium, and zinc levels in patients with COVID-19 A pilot case-control study found that median zinc levels in COVID-19 patients were roughly half those of controls.25European Journal of Clinical Nutrition. Low serum levels of zinc and 25-hydroxyvitmain D as potential risk factors for COVID-19 susceptibility: a pilot case-control study Patients who died tended to have the lowest serum zinc, vitamin D, and vitamin B12 levels at admission, though the differences for vitamin B12 and vitamin D did not always reach statistical significance.26PubMed Central. Evaluation of the relationship between serum levels of zinc, vitamin B12, vitamin D, and clinical outcomes in patients with COVID-19
A word of caution on interpretation: it is not always clear whether low micronutrient levels cause worse COVID-19 outcomes, or whether severe illness itself depletes these nutrients. Both are likely true to some degree. Zinc and vitamin D play genuine roles in immune function, and being deficient going into an infection is probably not helpful. But acute inflammation itself redistributes these nutrients, driving blood levels down even in people whose stores were adequate before they got sick. A low vitamin D reading during a hospital stay does not necessarily mean you were deficient before the virus hit.
Autoantibody Production
One of the more concerning blood work findings is that COVID-19 appears to trigger the production of autoantibodies, proteins that mistakenly target the body’s own tissues. A study comparing COVID-19 patients to healthy controls found that roughly one in every two to three COVID-19 patients tested positive for antinuclear antibodies (ANA), representing about a 2.5-fold increase over controls.27PubMed Central. Prevalence of anti-nuclear antibodies in COVID-19 patients: a remarkable 2.5-fold rise compared to healthy controls A separate cohort at the University of Pennsylvania found that about 14% of hospitalized COVID-19 patients were ANA-positive at diagnostically meaningful dilutions, with various patterns suggesting different types of autoimmune targeting.28Nature Communications. New-onset IgG autoantibodies in hospitalized patients with COVID-19
These autoantibodies do not always cause symptoms in the short term, but their presence raises the question of whether COVID-19 can serve as a trigger for autoimmune conditions down the line. This connects to the broader observation that post-infectious autoimmunity is not unique to SARS-CoV-2, but the scale at which it seems to happen with this virus has attracted serious research attention.
Long COVID and Persistent Blood Work Abnormalities
For many people, the relevant question is not what happens to blood work during acute infection, but what lingers afterward. The immune fingerprint of long COVID is becoming clearer. A longitudinal study found that people with long COVID had activated monocytes, specific subsets of exhausted CD8+ T cells expressing inhibitory markers (PD-1 and Tim-3), and sustained production of antiviral cytokines at three and eight months after infection. Encouragingly, by 24 months most of these immune markers had normalized, and gene-expression analysis showed no lasting T cell exhaustion signal at that point.29Nature Communications. Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection
A separate line of research has focused on microclots: tiny, abnormal fibrin-based clots circulating in the blood of long COVID patients. These microclots are structurally associated with markers shed by neutrophils and are found in elevated amounts in people with persistent symptoms.30PubMed Central. Circulating Microclots Are Structurally Associated With Neutrophil Extracellular Traps and Their Amounts Are Elevated in Long COVID Patients These clots may be resistant to normal breakdown and can trap other proteins, potentially contributing to the fatigue, brain fog, and exercise intolerance that characterize long COVID.31PubMed Central. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications There is also evidence pointing to persistent viral reservoirs and reactivation of latent viruses like Epstein-Barr virus as drivers of the ongoing immune disruption.32PubMed Central. The immunology of long COVID
Standard blood panels may look completely normal in someone with long COVID, which is a source of real frustration for patients and clinicians alike. The microclot and immune-subset findings come from specialized research assays not typically available in routine clinical labs. This mismatch helps explain why many long COVID patients are told their blood work is “fine” when they still feel unwell.
How COVID Blood Work Differs From the Flu
If both COVID-19 and influenza can cause fever, fatigue, and respiratory symptoms, you might wonder whether they look the same on a blood test. They do not. A direct comparison of COVID-19 and influenza B patients found that COVID-19 patients had higher white blood cell and neutrophil counts but lower red blood cell and lymphocyte counts.33PubMed Central. Comparison of Clinical Characteristics and Peripheral Blood Tests of COVID-19 and Influenza B Patients In children, a study comparing SARS-CoV-2, influenza A, and RSV found that COVID-19 cases had notably higher NLR and platelet counts compared to influenza A, though the overall diagnostic accuracy of any single blood marker was moderate at best.34PubMed Central. Diagnostic value of routine blood tests in differentiating between SARS-CoV-2, influenza A, and RSV infections in hospitalized children: a retrospective study In other words, the pattern of shifts can hint at which virus is responsible, but no routine blood test alone definitively distinguishes COVID-19 from influenza. A PCR or antigen test still does the actual identifying.
Vaccination and Blood Work
People sometimes worry that COVID-19 vaccines themselves cause the same blood work abnormalities as the infection. The evidence suggests the changes from vaccination are far smaller in magnitude and shorter in duration. A large study comparing vaccine-associated hematological events to infection-associated events found that the incidence of thrombocytopenia, leukopenia, and neutropenia per 10,000 COVID-19 cases dwarfed the incidence per 10,000 vaccine doses by orders of magnitude. For example, thrombocytopenia occurred in about 1,254 per 10,000 COVID cases, compared to roughly 1 to 3 per 10,000 vaccine doses depending on vaccine type.35PubMed Central. COVID‐19 vaccines and risks of hematological abnormalities: Nested case–control and self‐controlled case series study A small, transient risk of leukopenia was observed in the first two weeks following the second dose of BNT162b2 (Pfizer), but even that resolved quickly.
On the flip side, vaccination appeared to produce a favorable shift in red cell distribution width (RDW), a marker that had been associated with worse COVID-19 outcomes. Post-vaccination, RDW actually improved, suggesting more uniform red blood cell production, the opposite of what happens during active infection.36Acta Virologica. Hematological and inflammatory changes following Pfizer-BNT162b2 mRNA vaccination in young healthy adults The takeaway is that vaccination mimics a small, controlled immune response that does not produce the widespread blood work disruption characteristic of actual infection.
Using Routine Blood Tests to Predict Severity
One of the practical legacies of pandemic-era research is the realization that routine blood tests drawn at admission can help predict who is at risk for deterioration. Machine learning models trained on standard lab values identified a combination of five markers, including ferritin, serum iron, prothrombin activity, activated partial thromboplastin time, and monocyte count, that predicted severe disease with reasonable accuracy.37Anais da Academia Brasileira de Ciências. Determination of prognostic markers for COVID-19 disease severity using routine blood tests and machine learning High-sensitivity CRP and fibrinogen degradation products similarly showed strong predictive power for identifying which patients would progress to severe or life-threatening illness.7PubMed Central. Identification of parameters in routine blood and coagulation tests related to the severity of COVID-19
None of these markers work in isolation. A single elevated CRP or a mildly low lymphocyte count does not mean you are headed for the ICU. The clinical value comes from looking at the constellation of changes together, in the context of your symptoms, age, and pre-existing conditions. If you are reviewing your own blood work after a COVID-19 infection, the most useful thing is to share the results with your doctor, who can interpret the pattern rather than any individual number.